133 related articles for article (PubMed ID: 30189384)
1. Neuronal surface antibody-mediated encephalopathy as manifestation of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Pirotte M; Forte F; Lutteri L; Willems E; Duran U; Belle L; Baron F; Beguin Y; Maquet P; Bodart O; Servais S
J Neuroimmunol; 2018 Oct; 323():115-118. PubMed ID: 30189384
[TBL] [Abstract][Full Text] [Related]
2. FDG PET/CT in Acute Tumefactive Multiple Sclerosis Occurring in a Case of Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation.
Dong A; Gao M; Wang Y; Gao L; Zuo C
Clin Nucl Med; 2016 Sep; 41(9):e414-6. PubMed ID: 26909714
[TBL] [Abstract][Full Text] [Related]
3. Immune Mediated Cerebellar Ataxia: An Unknown Manifestation of Graft-versus-Host Disease.
Shargian-Alon L; Raanani P; Rozovski U; Siegal T; Yust-Katz S; Yeshurun M
Acta Haematol; 2019; 141(1):19-22. PubMed ID: 30439710
[TBL] [Abstract][Full Text] [Related]
4. Antineutrophil cytoplasmic antibody-associated glomerulonephritis in chronic graft-versus-host disease after allogenic hematopoietic stem cell transplantation.
Nouri-Majelan N; Sanadgol H; Ghafari A; Rahimian M; Najafi F; Mortazavizadeh M; Moghaddasi S
Transplant Proc; 2005 Sep; 37(7):3213-5. PubMed ID: 16213351
[TBL] [Abstract][Full Text] [Related]
5. [Acute and chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation].
Barzin A; Geurten C; Willems E; Baron F; Beguin Y; Servais S
Rev Med Liege; 2022 May; 77(5-6):345-353. PubMed ID: 35657193
[TBL] [Abstract][Full Text] [Related]
6. Relapsing polymyositis in chronic graft versus host disease.
Sharaf N; Prayson RA
J Clin Neurosci; 2014 Nov; 21(11):1964-5. PubMed ID: 24980629
[TBL] [Abstract][Full Text] [Related]
7. Graft-versus-host disease after radiation therapy in patients who have undergone allogeneic stem cell transplantation: two case reports.
Milgrom SA; Nieto Y; Pinnix CC; Smith GL; Wogan CF; Rondon G; Medeiros LJ; Kebriaei P; Dabaja BS
J Med Case Rep; 2016 Jul; 10():209. PubMed ID: 27465468
[TBL] [Abstract][Full Text] [Related]
8. A case of central nervous system graft-versus-host disease following allogeneic stem cell transplantation.
Min GJ; Park S; Park SS; Yoon JH; Lee SE; Cho BS; Eom KS; Lee S; Kim HJ; Min CK; Cho SG; Kim DW; Lee JW; Kim YJ
Int J Hematol; 2019 Nov; 110(5):635-639. PubMed ID: 31309419
[TBL] [Abstract][Full Text] [Related]
9. The black swan: a case of central nervous system graft-versus-host disease.
Butera S; Tavarozzi R; Brunello L; Rivela P; Sofia A; Viero L; Salvio M; Ladetto M; Zallio F
J Basic Clin Physiol Pharmacol; 2023 Nov; 34(6):805-809. PubMed ID: 37843253
[TBL] [Abstract][Full Text] [Related]
10. Case report: Central nervous system involvement of human graft versus host disease: Report of 7 cases and a review of literature.
Ruggiu M; Cuccuini W; Mokhtari K; Meignin V; Peffault de Latour R; Robin M; Fontbrune FS; Xhaard A; Socié G; Michonneau D
Medicine (Baltimore); 2017 Oct; 96(42):e8303. PubMed ID: 29049232
[TBL] [Abstract][Full Text] [Related]
11. Muscle cramps and neuropathies in patients with allogeneic hematopoietic stem cell transplantation and graft-versus-host disease.
Kraus PD; Wolff D; Grauer O; Angstwurm K; Jarius S; Wandinger KP; Holler E; Schulte-Mattler W; Kleiter I
PLoS One; 2012; 7(9):e44922. PubMed ID: 23028681
[TBL] [Abstract][Full Text] [Related]
12. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
13. Severe allo-immune antibody-associated peripheral and central nervous system diseases after allogeneic hematopoietic stem cell transplantation.
Hümmert MW; Stadler M; Hambach L; Gingele S; Bredt M; Wattjes MP; Göhring G; Venturini L; Möhn N; Stangel M; Trebst C; Ganser A; Wegner F; Skripuletz T
Sci Rep; 2021 Apr; 11(1):8527. PubMed ID: 33875720
[TBL] [Abstract][Full Text] [Related]
14. Histological evaluation of acute mucocutaneous graft-versus-host disease in nonmyeloablative hematologic stem cell transplants with an observation predicting an increased risk of progression to chronic graft-versus-host disease.
Bridge AT; Nelson RP; Schwartz JE; Mirowski GW; Billings SD
Am J Dermatopathol; 2007 Feb; 29(1):1-6. PubMed ID: 17284954
[TBL] [Abstract][Full Text] [Related]
15. Cecum ulcer is a reliable endoscopic finding in cytomegalovirus colitis concomitant with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Matsuda K; Ono S; Ishikawa M; Miyamoto S; Abiko S; Tsuda M; Yamamoto K; Kudo T; Shimizu Y; Hayase E; Hashimoto D; Teshima T; Matsuno Y; Sakamoto N
Ann Hematol; 2018 May; 97(5):877-883. PubMed ID: 29340759
[TBL] [Abstract][Full Text] [Related]
16. [Central nervous system involvement of graft versus host disease after allogeneic hematopoietic stem cell transplantation for adult T cell leukemia].
Ide T; Iida K; Katsuya H; Ito H; Aishima S; Hara H
Rinsho Shinkeigaku; 2022 Jan; 62(1):33-38. PubMed ID: 34924471
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of meningeal graft-versus-host disease in a haematopoietic stem cell transplant recipient.
Pechey V; Parratt J; Vo L; Stevenson W
Int J Hematol; 2015 Feb; 101(2):203-6. PubMed ID: 25416235
[TBL] [Abstract][Full Text] [Related]
18. Invasive fungal disease is associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplant: a single center, retrospective study.
Jin H; Fan Z; Huang F; Chai Y; Xuan L; Lin R; Xu N; Ye J; Sun J; Liu Q
Infection; 2019 Apr; 47(2):275-284. PubMed ID: 30734248
[TBL] [Abstract][Full Text] [Related]
19. Central nervous system complications after allogeneic hematopoietic stem cell transplantation: incidence, manifestations, and clinical significance.
Siegal D; Keller A; Xu W; Bhuta S; Kim DH; Kuruvilla J; Lipton JH; Messner H; Gupta V
Biol Blood Marrow Transplant; 2007 Nov; 13(11):1369-79. PubMed ID: 17950923
[TBL] [Abstract][Full Text] [Related]
20. Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and Rituximab Is Associated with Improved Outcomes Compared with Fludarabine and Busulfan after Allogeneic Stem Cell Transplantation for B Cell Malignancies.
Kennedy VE; Savani BN; Greer JP; Kassim AA; Engelhardt BG; Goodman SA; Sengsayadeth S; Chinratanalab W; Jagasia M
Biol Blood Marrow Transplant; 2016 Oct; 22(10):1801-1807. PubMed ID: 27377900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
